期刊文献+

甾体5α-还原酶抑制剂LTZ-8和类似物的筛选及其抗前列腺增生作用(英文) 被引量:4

The screening and anti-prostatic hyperplasia activity assessment of novel steroid 5α-reductase inhibitors LTZ-8 and others
下载PDF
导出
摘要 目的 为筛选新的不同结构的甾体 5α 还原酶抑制剂LTZ 8等抗前列腺增生药物 (在C 3,C 4,C 1 7具有不同基团的睾酮衍生物 )。方法 同位素筛选法检测LTZ 8对体外 5α 还原酶的抑制能力。体内动物模型选用去势大鼠 (注射丙酸睾酮刺激前列腺重新生长 ) ,连续灌胃LTZ 8(3 ,1 0及 30mg·kg-1 ,每日 1次 ) 30d ,检测前列腺组织绝对重量和相对重量 ,并对前列腺上皮进行组织形态学分析。结果 LTZ 1 ,LTZ 5,LTZ 6和LTZ 8均有抑制 5α 还原酶的作用 ,其中LTZ 8的作用最强〔Ki=(2 1 .0±2 .2 )nmol·L-1 〕。大鼠口服 30mg·kg-1 LTZ 8,前列腺湿重和干重分别为对照组的 82 %和 86% (P <0 .0 5)。前列腺上皮细胞高度和腺腔面积呈剂量依赖性下降。结论 LTZ 8具有抑制 5α 还原酶的活性 。 AIM To screen new anti-prostatic hyperplasia drugs LTZ-8 an d others(testosterone derivatives with different groups at C-3, C-4 and C-17) , which are different structures of steroid 5α-reductase inhibitors. METHODS Isotope screening method was used to determine the ability o f LTZ-8 to inhibit steroid 5α-reductase in vitro. Healthy male ra ts, which were castrated and injected testosterone to induce the regrowth of gla ndular cells, were selected as animal model. LTZ-8 was given orally once a day (3, 10 and 30 mg·kg -1 ) for 30 d. Wet and dry prostate weight was quantifi ed and morphological structures of prostate were detected under light microscope . RESULTS LTZ-1, LTZ-5, LTZ-6 and LTZ-8 showed inhibitory effec t on the activity of 5α-reductase,and LTZ-8 was the most effective one 〔K i=(21.0± 2.2)nmol·L -1 〕. Both the wet and dry prostate we ight was reduced by 82% and 86% in LTZ-8 treated group (30 mg·kg -1 ) compared with control group respectively (P&lt;0.05). Prostatic glandular cell height and acinar luminal area were decreased by LTZ-8 treatment in a dose-dep endent manner. CONCLUSION LTZ-8 inhibits steroid 5α-reductase activity in vitroand blocks the prostatic hyperplasia in testostero ne-induced castrated rats.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2003年第5期395-400,共6页 Chinese Journal of Pharmacology and Toxicology
关键词 抗前列腺增生 氧化还原酶类 睾酮衍生物 LTZ-8 甾体5α-还原酶抑制剂 prostatic hyperplasia oxidoreductases testosterone deri vatives LTZ-8
  • 相关文献

参考文献15

  • 1Levy MA, Brandt M, Sheedy KM, Dinh JT, Holt DA, Garrison LM, et al. Epnsteride is a selective and specific uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2[J]. J Steroid Biochem Mol Biol, 1994, 48(2 -3) : 197- 206.
  • 2Schroder FH. 5 Alpha-reductae inhibitors and prostatic disease[J]. Clin Endocrinol (Oxf), 1994, 41(2) : 139 -147.
  • 3Horton. Benign prostatic hyperplasia: new insights[ J]. J Clin Endocrinal Metab, 1992, 74(3) :.504A - 504C.
  • 4Tempany CM, Partin AW, Zerhouni EA, Zinreich SJ, Walsh PC. The influence of finasteride on the volume of the peripizral and periurethral zones of the prostate in men with benign prostatic hyperplasia[J]. Prostate, 1993, 22(1):39 - 42.
  • 5Celler J, Kirchenbaum A, Lepor H, Levine AC. Therapeutic cortroversies: clinical treatment of benign prostatic[J]. J Clin Endocrinol Metab, 1995, 80(3):745 - 747.
  • 6Ahmed S, Denison S. Structure activity relationship study of known inhibitors of the enzyme 5 alpha-reduetase (5AR) [J]. Bioorg Med Chem Lett, 1998, 8(5) :409- 414.
  • 7Sun ZY, Tu ZH. A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia[J]. Methods Find Exp Clin Pharmacol, 1998, 20(4) :283-287.
  • 8Liang T, Heiss CE, Ostrove S, Rasmusson GH, Cheung A. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes[J]. Endocrinology, 1983, 112(4) : 1460 - 1468.
  • 9Krieg M, Weisser H, Tunn S. Potential aoivities of androgen metagbolizing enzymes in human prostate[J]. J Steroid Biochem Mol Bid, 1995, 53(1-6):395-400.
  • 10Segel IH. Enzyme[A]. Biochemical calculations: How to Solve Mathematical Problems in General Biochemistry[M]. Vol 2. California: John Wiley & Sons, Inc, 1976. 174-202.

同被引文献16

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部